Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $157.88 +0.71%
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Scotiabank Starts Affirm Holdings (AFRM) at Sector Outperform
- BofA downgrades Amrize to underperform, cuts price target on slower growth outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
